Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing

Although it is widely accepted that patients, who are considered poor responders to in vitro fertilization (IVF) benefit from recombinant luteinizing hormone (rLH) supplementation during an in vitro fertilization cycle, particularly when gonadotropin-releasing hormone (GnRH) antagonist (ant) treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: GIZZO, SALVATORE, ANDRISANI, ALESSANDRA, NOVENTA, MARCO, MANFÈ, SERENA, OLIVA, ALESSANDRA, GANGEMI, MICHELE, NARDELLI, GIOVANNI BATTISTA, AMBROSINI, GUIDO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526099/
https://www.ncbi.nlm.nih.gov/pubmed/26059981
http://dx.doi.org/10.3892/mmr.2015.3904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526099/
https://www.ncbi.nlm.nih.gov/pubmed/26059981
http://dx.doi.org/10.3892/mmr.2015.3904

Ejemplares similares